Dr. Bardhan Cook is chief innovation officer at Fox Chase Cancer Center and senior vice president of commercialization strategy and business development at Philadelphia-based Temple University Health System, where she leads translational strategy across digital transformation, diagnostics and therapeutics. Since joining in August 2022, she has shifted commercialization efforts toward de-risking early-stage technologies, prioritizing maturation of discoveries to improve investor and partner readiness rather than pursuing immediate patenting. She is advancing industry-academic alliances for multi-cancer early detection and minimal residual disease testing and forming an accelerator to translate proprietary cancer diagnostic assays to patients with supporting infrastructure investment. Dr. Bardhan Cook is also developing partnerships to strengthen radiopharmaceutical supply through a fully integrated contract development and manufacturing organization relationship and is building a program to harness patient multi-omic information to generate new clinical insights. Her portfolio includes collaboration with an AI company to prepare radiology images for model training and leadership of clinical development for a first-in-class therapeutic originating from Fox Chase discovery. Dr. Bardhan Cook has been recognized as a 2025 “IAM Strategy 300” designee.
